Abstract
We report a novel gold nanobioconjugate system that achieves targeted delivery of the small molecule drug doxorubicin to endothelial cells using anti-VEGFR-2 antibody conjugated gold nanoparticles (GNPs). The reported nanobioconjugate system combines the inherent ability of GNPs to undergo high levels of derivatization with the precision of antibody recognition of a cell surface antigen. Transmission electron microscopy (TEM) and surface-enhanced Raman spectroscopy (SERS) confirmed intracellular presence of the GNPs. Using a VEGFR-2 expressing cell line and a cell line that is negative for the receptor, in combination with competition assay we established the cell specific targeted delivery of the nanobioconjugate. The nanobioconjugate system described here may have potential drug delivery applications for antiangiogenic cancer therapy.
References
Asadishad B, Vossoughi M, Alamzadeh I (2010a) In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells. Biotechnol Lett 32(5):649–654
Asadishad B, Vossoughi M, Alemzadeh I (2010b) Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles. Ind Eng Chem Res 49(4):1958–1963
Bergen JM, Von Recum HA, Goodman TT, Massey AP, Pun SH (2006) Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci 6(7):506–516
Chari RVJ (1998) Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy. Adv Drug Deliv Rev 31(1–2):89–104
Chen J, Wu H, Han D, Xie C (2006) Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer. Cancer Lett 231(2):169–175
Chen YH, Tsai CY, Huang PY, Chang MY, Cheng PC, Chou CH, Chen DH, Wang CR, Shiau AL, Wu CL (2007) Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 4(5):713–722
Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662–668
Daniel MC, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104(1):293–346
Dixit V, Van den Bossche J, Sherman DM, Thompson DH, Andres RP (2006) Synthesis and grafting of thioctic acid-PEG-folate conjugates onto au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug Chem 17(3):603–609
Eliasson C, Loren A, Engelbrektsson J, Josefson M, Abrahamsson J, Abrahamsson K (2005) Surface-enhanced Raman scattering imaging of single living lymphocytes with multivariate evaluation. Spectrochim Acta A 61(4):755–760
El-Sayed IH, Huang XH, El-Sayed MA (2005) Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 5(5):829–834
Ganesh T (2007) Improved biochemical strategies for targeted delivery of taxoids. Bioorg Med Chem 15(11):3597–3623
Ghosh SK, Pal A, Kundu S, Nath S, Pal T (2004) Fluorescence quenching of 1-methylaminopyrene near gold nanoparticles: size regime dependence of the small metallic particles. Chem Phys Lett 395(4–6):366–372
Gibson JD, Khanal BP, Zubarev ER (2007) Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 129(37):11653–11661
Gray GD, Basu S, Wickstrom E (1997) Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3′-alkylamino oligodeoxynucleotides, 2′-o-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids. Biochem Pharmacol 53(10):1465–1476
Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90(12):1927–1936
Holder JM, Wynn-Williams DD, Perez FR, Edwards HGM (2000) Raman spectroscopy of pigments and oxalates in situ within epilithic lichens: Acarospora from the antarctic and mediterranean. New Phytol 145(2):271–280
Hong R, Han G, Fernãndez JM, Kim B, Forbes NS, Rotello VM (2006) Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J Am Chem Soc 128(4):1078–1079
Huang XH, Jain PK, El-Sayed IH, El-Sayed MA (2006) Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem Photobiol 82(2):412–417
Jaracz S, Chen J, Kuznetsova LV, Ojima L (2005) Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 13(17):5043–5054
Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K (2006a) In vivo molecular probing of cellular compartments with gold nanoparticles and nanoaggregates. Nano Lett 6(10):2225–2231
Kneipp K, Kneipp H, Kneipp J (2006b) Surface-enhanced Raman scattering in local optical fields of silver and gold nanoaggregatess—from single-molecule Raman spectroscopy to ultrasensitive probing in live cells. Acc Chem Res 39(7):443–450
Liu CN, Tadayoni BM, Bourret LA, Mattocks KM, Derr SM, Widdison WC, Kedersha NL, Ariniello PD, Goldmacher VS, Lambert JM, Blattler WA, Chari RVJ (1996) Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc Natl Acad Sci USA 93(16):8618–8623
Lu GW, Xia HR, Wang XQ, Xu D, Chen Y, Zhou YQ (2001) Raman scattering investigation of the zinc cadmium tetrathiocyanate single crystals. Mater Sci Eng B 87(2):117–121
Oyelere AK, Chen PC, Huang XH, El-Sayed IH, El-Sayed MA (2007) Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug Chem 18(5):1490–1497
Paciotti GF, Kingston DGI, Tamarkin L (2006) Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Chembiochem 67(1):47–54
Patra CR, Bhattacharya R, Wang E, Katarya A, Lau JS, Dutta S, Muders M, Wang S, Buhrow SA, Safgren SL, Yaszemski MJ, Reid JM, Ames MM, Mukherjee P, Mukhopadhyay D (2008) Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res 68(6):1970–1978
Roberts WG, Delaat J, Nagane M, Huang S, Cavenee WK, Palade GE (1998) Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 153(4):1239–1248
Scott RC, Wang B, Nallamothu R, Pattillo CB, Perez-Liz G, Issekutz A, Del Valle L, Wood GC, Kiani MF (2007) Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction. Biotechnol Bioeng 96(4):795–802
Shao N, Lu S, Wickstrom E, Panchapakesan B (2007) Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology 18(31):315101
Speelmans G, Staffhorst RWHM, Steenbergen HG, de Kruijff B (1996) Transport of the anti-cancer drug doxorubicin across cytoplasmic membranes and membranes composed of phospholipids derived from Escherichia coli occurs via a similar mechanism. Biochim Biophys Acta (BBA) 1284(2):240–246
Tkachenko AG, Xie H, Coleman D, Glomm W, Ryan J, Anderson MF, Franzen S, Feldheim DL (2003) Multifunctional gold nanoparticle–peptide complexes for nuclear targeting. J Am Chem Soc 125(16):4700–4701
Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P, Böhlen P (1998) Monoclonal antibodies targeting the VEGF receptor-2 (flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev 17(2):155–161
Yang PH, Sun XS, Chiu JF, Sun HZ, He QY (2005) Transferrin-mediated gold nanoparticle cellular uptake. Bioconjug Chem 16(3):494–496
Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK, Kim DD (2007a) Preparation and evaluation of paclitaxel-loaded pegylated immunoliposome. J Control Rel 120(3):169–177
Yang J, Lee CH, Ko HJ, Suh JS, Yoon HG, Lee K, Huh YM, Haam S (2007b) Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew Chem Int Ed 46(46):8836–8839
Acknowledgments
This work was supported by a start-up fund from Kent State University to SB. AH was supported by the National Science Foundation through an NSF-REU summer fellowship.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Das, A., Soehnlen, E., Woods, S. et al. VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy. J Nanopart Res 13, 6283–6290 (2011). https://doi.org/10.1007/s11051-011-0300-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-011-0300-8